Reshma Rangwala - EVP & Chief Medical Officer at Karyopharm Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP & Chief Medical Officer
Stock Symbol
KPTI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Reshma Rangwala - trading volume in the past year for Karyopharm Therapeutics Inc.

Holdings reported by Reshma Rangwala for Karyopharm Therapeutics Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common 349,720 $420 K $1.20 Mar 1, 2024 Direct
Common Stock 342,931 $401 K $1.17 Apr 22, 2024 Direct

Transactions reported by Reshma Rangwala for Karyopharm Therapeutics Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership